HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular basis for negative regulation of the glucagon receptor.

Abstract
Members of the class B family of G protein-coupled receptors (GPCRs) bind peptide hormones and have causal roles in many diseases, ranging from diabetes and osteoporosis to anxiety. Although peptide, small-molecule, and antibody inhibitors of these GPCRs have been identified, structure-based descriptions of receptor antagonism are scarce. Here we report the mechanisms of glucagon receptor inhibition by blocking antibodies targeting the receptor's extracellular domain (ECD). These studies uncovered a role for the ECD as an intrinsic negative regulator of receptor activity. The crystal structure of the ECD in complex with the Fab fragment of one antibody, mAb1, reveals that this antibody inhibits glucagon receptor by occluding a surface extending across the entire hormone-binding cleft. A second antibody, mAb23, blocks glucagon binding and inhibits basal receptor activity, indicating that it is an inverse agonist and that the ECD can negatively regulate receptor activity independent of ligand binding. Biochemical analyses of receptor mutants in the context of a high-resolution ECD structure show that this previously unrecognized inhibitory activity of the ECD involves an interaction with the third extracellular loop of the receptor and suggest that glucagon-mediated structural changes in the ECD accompany receptor activation. These studies have implications for the design of drugs to treat class B GPCR-related diseases, including the potential for developing novel allosteric regulators that target the ECDs of these receptors.
AuthorsChristopher M Koth, Jeremy M Murray, Susmith Mukund, Azadeh Madjidi, Alexandra Minn, Holly J Clarke, Terence Wong, Vicki Chiang, Elizabeth Luis, Alberto Estevez, Jesus Rondon, Yingnan Zhang, Isidro Hötzel, Bernard B Allan
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 109 Issue 36 Pg. 14393-8 (Sep 04 2012) ISSN: 1091-6490 [Electronic] United States
PMID22908259 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Receptors, Glucagon
Topics
  • Amino Acid Sequence
  • Antibodies, Monoclonal (metabolism, pharmacology)
  • Blotting, Western
  • Cell Line
  • Chromatography, Affinity
  • Crystallography
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Immunoglobulin Fab Fragments (metabolism)
  • Models, Molecular
  • Molecular Sequence Data
  • Mutagenesis
  • Protein Conformation
  • Protein Structure, Tertiary (genetics)
  • Receptors, Glucagon (antagonists & inhibitors, chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: